On this premise, a candidate tumor suppressor role for PER1 in liver cancer should be carefully evaluated in the context of a lack of macroH2A1 histones, but at the same time could represent a potential molecular target with implications for therapeutic strategies. This evidence concerns the gene MACROH2A1 and neoplasm.